Study Of The Safety And Efficacy Of Conversion From A CNI To Sirolimus In Renally-Impaired Heart Transplant Recipients
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to determine whether converting from calcineurin
inhibitor (CNI) therapy to sirolimus therapy will be more effective than continuing
calcineurin inhibitor therapy with respect to renal function in cardiac transplant recipients
with mild to moderate renal dysfunction.